180 related articles for article (PubMed ID: 29535501)
1. Integration of microRNA-mRNA profiles and pathway analysis of plant isoquinoline alkaloid berberine in SGC-7901 gastric cancers cells.
Yang Y; Zhang N; Li K; Chen J; Qiu L; Zhang J
Drug Des Devel Ther; 2018; 12():393-408. PubMed ID: 29535501
[TBL] [Abstract][Full Text] [Related]
2. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF
Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y
Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.
Luo X; Gu J; Zhu R; Feng M; Zhu X; Li Y; Fei J
BMC Syst Biol; 2014 Jul; 8():82. PubMed ID: 25000828
[TBL] [Abstract][Full Text] [Related]
4. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6.
Xu M; Ren L; Fan J; Huang L; Zhou L; Li X; Ye X
Life Sci; 2022 Feb; 290():120266. PubMed ID: 34968467
[TBL] [Abstract][Full Text] [Related]
5. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
Jabbarzadeh Kaboli P; Luo S; Chen Y; Jomhori M; Imani S; Xiang S; Wu Z; Li M; Shen J; Zhao Y; Wu X; Hin Cho C; Xiao Z
Gene; 2022 Mar; 816():146171. PubMed ID: 35026293
[TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a ∼ 125b cluster function by seed-targeting inhibitors in multiple myeloma cells.
Feng M; Luo X; Gu C; Li Y; Zhu X; Fei J
RNA Biol; 2015; 12(1):82-91. PubMed ID: 25826415
[TBL] [Abstract][Full Text] [Related]
8. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling.
Wu K; Yang Q; Mu Y; Zhou L; Liu Y; Zhou Q; He B
Int J Oncol; 2012 Jul; 41(1):292-8. PubMed ID: 22469784
[TBL] [Abstract][Full Text] [Related]
9. Cell Cycle Regulation by Berberine in Human Melanoma A375 Cells.
Ren M; Yang L; Li D; Yang L; Su Y; Su X
Bull Exp Biol Med; 2020 Aug; 169(4):491-496. PubMed ID: 32915362
[TBL] [Abstract][Full Text] [Related]
10. A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine.
Lee KH; Lo HL; Tang WC; Hsiao HH; Yang PM
Sci Rep; 2014 Sep; 4():6394. PubMed ID: 25227736
[TBL] [Abstract][Full Text] [Related]
11. Berberine inhibits the proliferation of human uterine leiomyoma cells.
Wu HL; Chuang TY; Al-Hendy A; Diamond MP; Azziz R; Chen YH
Fertil Steril; 2015 Apr; 103(4):1098-106. PubMed ID: 25682924
[TBL] [Abstract][Full Text] [Related]
12. Plant Isoquinoline Alkaloid Berberine Exhibits Chromatin Remodeling by Modulation of Histone Deacetylase To Induce Growth Arrest and Apoptosis in the A549 Cell Line.
Kalaiarasi A; Anusha C; Sankar R; Rajasekaran S; John Marshal J; Muthusamy K; Ravikumar V
J Agric Food Chem; 2016 Dec; 64(50):9542-9550. PubMed ID: 27936791
[TBL] [Abstract][Full Text] [Related]
13. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.
Cao W; Yang W; Fan R; Li H; Jiang J; Geng M; Jin Y; Wu Y
Tumour Biol; 2014 Feb; 35(2):1287-95. PubMed ID: 24068565
[TBL] [Abstract][Full Text] [Related]
14. Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR‑429.
Gu Y; Zhou Z
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846796
[TBL] [Abstract][Full Text] [Related]
15. Matrine alters microRNA expression profiles in SGC-7901 human gastric cancer cells.
Li H; Xie S; Liu X; Wu H; Lin X; Gu J; Wang H; Duan Y
Oncol Rep; 2014 Nov; 32(5):2118-26. PubMed ID: 25174809
[TBL] [Abstract][Full Text] [Related]
16. Berberine: A potential adjunct for the treatment of gastrointestinal cancers?
Hesari A; Ghasemi F; Cicero AFG; Mohajeri M; Rezaei O; Hayat SMG; Sahebkar A
J Cell Biochem; 2018 Dec; 119(12):9655-9663. PubMed ID: 30125974
[TBL] [Abstract][Full Text] [Related]
17. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway.
Li C; Liu DR; Li GG; Wang HH; Li XW; Zhang W; Wu YL; Chen L
World J Gastroenterol; 2015 May; 21(20):6215-28. PubMed ID: 26034356
[TBL] [Abstract][Full Text] [Related]
18. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway.
Guo XH; Jiang SS; Zhang LL; Hu J; Edelbek D; Feng YQ; Yang ZX; Hu PC; Zhong H; Yang GH; Yang F
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34643248
[TBL] [Abstract][Full Text] [Related]
19. Berberine inhibits proliferation and induces G0/G1 phase arrest in colorectal cancer cells by downregulating IGF2BP3.
Zhang Y; Liu X; Yu M; Xu M; Xiao Y; Ma W; Huang L; Li X; Ye X
Life Sci; 2020 Nov; 260():118413. PubMed ID: 32926933
[TBL] [Abstract][Full Text] [Related]
20. Berberine promotes proliferation of sodium nitroprusside-stimulated rat chondrocytes and osteoarthritic rat cartilage via Wnt/β-catenin pathway.
Zhou Y; Tao H; Li Y; Deng M; He B; Xia S; Zhang C; Liu S
Eur J Pharmacol; 2016 Oct; 789():109-118. PubMed ID: 27445236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
